Американское общество гирудотерапии

C-terminal peptide alcohol, acid and amide analogs of desulfato hirudin54-65 as antithrombin agents

Research article published in Thrombosis research (1989)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportРазработка лекарственных препаратовKrstenansky JL et al. · Thrombosis research, 1989

Abstract

Analogs of the antithrombin peptide hirudin54-65 with C-terminal modifications have been synthesized in order to examine the requirements for alpha-thrombin inhibition. The C-terminal residue, Gln65, could be replaced with L-amino acids or amino alcohols with neutral or charged hydrophilic side chains without greatly affecting the peptide's antithrombin potency as determined by inhibition of thrombin-induced clot formation in human plasma in vitro. Derivatives with D- or L-amino carboxamides at position 65 had significantly reduced potency, but still retained activity. Deletion of residue 65 with conversion of residue 64 to the amide or alcohol derivative resulted in a three-fold loss of potency. In addition to these results the solid-phase synthesis of peptide alcohols via direct displacement of p-nitrobenzhydrylideneisonitroso resin attached peptides with the desired C-terminal amino alcohol is reported.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAcidsAlcoholsAmidesAntithrombinsFemaleFibrinHirudinsHumansIn Vitro TechniquesPeptides

Резюме

Analogs of the antithrombin peptide hirudin54-65 with C-terminal modifications have been synthesized in order to examine the requirements for alpha-thrombin inhibition.

Почему это важно для гирудотерапии

This study synthesized C-terminal analogs of the antithrombin peptide hirudin54-65 with modifications at position 65 to examine the structural requirements for alpha-thrombin inhibition, measuring potency by inhibition of thrombin-induced clot formation in human plasma in vitro. Replacement of the C-terminal residue with L-amino acids or amino alcohols having neutral or charged hydrophilic side chains did not greatly affect antithrombin potency, whereas derivatives with D- or L-amino carboxamides at position 65 showed significantly reduced but retained activity; deletion of residue 65 produced a three-fold loss of potency. Because the abstract explicitly names hirudin54-65 as the parent peptide, the work has a defensible biochemical relevance to ASH's domain as a structure-activity study of a hirudin fragment. However, the abstract makes no mention of leeches, leech saliva, leech secretome, or hirudotherapy, and the study is purely in vitro.

Цитирование

C-terminal peptide alcohol, acid and amide analogs of desulfato hirudin54-65 as antithrombin agents

Krstenansky JL et al. · Thrombosis research, 1989

Связанный клинический контекст

Узнайте, как это исследование связано с клинической практикой

Добавлено в библиотеку ASH: May 27, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.